Connect your AI

Microbot Medical MBOT Stock Issued During Period Value Warrants Exercised

Stock Issued During Period Value Warrants Exercised at other companies

TidewaterTDW

$1K-100.0%

Quantum Computing Inc.QUBT

$12K—

OS TherapiesOSTX

$2.35M—

DJT

Trump Media & Technology GroupDJT

$94.1K-57.5%

AvePoint, Inc.AVPT

$0-100%

CorMedixCRMD

$750—

Other financials

Income statement

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept MBOT:StockIssuedDuringPeriodValueWarrantsExercised.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's stock issued during period value warrants exercised.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Microbot Medical's stock issued during period value warrants exercised?: Microbot Medical (MBOT) reported stock issued during period value warrants exercised of $163K in Q4 2025.
What does stock issued during period value warrants exercised mean?: The total value of common stock issued upon the exercise of outstanding warrants by holders. This indicates the conversion of derivative instruments into equity, which impacts the total share count and capital structure.